Basso Stephen 4
4 · Inozyme Pharma, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2021-03-04+27,000→ 27,000 totalExercise: $19.78Exp: 2031-03-03→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2021. The shares underlying the option are scheduled to vest in equal monthly installments from March 4, 2021 through March 4, 2025.